Pharmascience Inc is proud to announce that it has acquired Uman Pharma Inc. on November 13, 2014.



Who we are


Founded 30 years ago in Montreal, where its headquarters remain, privately held Pharmascience Inc. is Canada’s 10th-largest pharmaceutical company. Its generic drug division is Canada’s third largest.  It also makes and distributes patented prescription and over-the-counter treatments through its Pendopharm division. Through its International Division, its products are exported to over 60 countries around the world. Pharmascience is one of Canada’s leading corporate investors in research and development and employs more than 1,400 people, primarily in Montreal.                                                                                                    

 

Pharmascience's Global Injectable Division is a fully-integrated pharmaceutical company that develops, manufactures and markets generic injectable pharmaceutical products and is the only oncology plant in Canada featuring a lyophilizer and pre-filled syringe capabilities.

 

We also offer manufacturing services to clients and partners internationally.

 

We bring together experienced people dedicated to high-quality health products to offer:

  • Generic cytotoxic injectable drugs
  • Innovative solutions that will benefit hospital health professionals
  • Manufacturing of high quality drugs meeting international pharmaceutical standards: TPD (Canada), EMEA (Europe) and FDA (USA)
  • Services to clients and partners in both injectable (liquid and lyophilized vials or pre-filled syringes) and visual inspection as well as packaging.


Together with its partners, Pharmascience is developing a comprehensive portfolio of  specialty oncology products.

Who we are

Who we are




Pharmascience Inc.

100, de l'Industrie Boulevard, Candiac, Québec, Canada, J5R 1J1

(450) 444-9989 / 1 877 444-9989


Contact us


© 2017 Pharmascience inc. All rights reserved. Website design by Vortex Solution